Holen Sie sich die Stockscreener-App
3.12
0.95%
-0.03
Handel nachbörslich:
3.13
0.010
+0.32%
Schlusskurs vom Vortag:
$3.15
Offen:
$3.15
24-Stunden-Volumen:
1.73M
Relative Volume:
0.67
Marktkapitalisierung:
$625.15M
Einnahmen:
$216.56M
Nettoeinkommen (Verlust:
$-9.57M
KGV:
-62.78
EPS:
-0.0497
Netto-Cashflow:
$-1.22M
1W Leistung:
-1.27%
1M Leistung:
+21.88%
6M Leistung:
+51.46%
1J Leistung:
+101.29%
1-Tages-Spanne:
$3.02
$3.165
1-Wochen-Bereich:
$3.02
$3.4698
52-Wochen-Spanne:
$1.15
$3.4698
Cerus Corp Stock (CERS) Company Profile
Firmenname
Cerus Corp
Sektor
Branche
Telefon
(925) 288-6000
Adresse
1220 CONCORD AVENUE, CONCORD, CA
Compare CERS vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CERS
Cerus Corp
|
3.12 | 625.15M | 216.56M | -9.57M | -1.22M | -0.0497 |
ABT
Abbott Laboratories
|
93.93 | 163.61B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
329.78 | 126.42B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
83.87 | 107.36B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
44.77 | 66.54B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
92.21 | 53.09B | 6.30B | 1.07B | 1.09B | 1.8406 |
Cerus Corp Stock (CERS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-04-12 | Eingeleitet | Craig Hallum | Buy |
| 2023-01-20 | Herabstufung | BTIG Research | Buy → Neutral |
| 2023-01-17 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2020-10-08 | Fortgesetzt | BTIG Research | Buy |
| 2020-06-16 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2020-02-26 | Eingeleitet | BTIG Research | Buy |
| 2019-11-13 | Hochstufung | BTIG Research | Neutral → Buy |
| 2019-08-28 | Eingeleitet | Stifel | Buy |
| 2019-08-23 | Fortgesetzt | Stephens | Overweight |
| 2018-01-05 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2017-12-08 | Fortgesetzt | BTIG Research | Neutral |
| 2016-07-07 | Fortgesetzt | Cantor Fitzgerald | Buy |
| 2015-12-17 | Herabstufung | Wedbush | Outperform → Neutral |
| 2014-05-02 | Bestätigt | MLV & Co | Buy |
| 2013-04-24 | Bestätigt | Cantor Fitzgerald | Buy |
| 2013-03-15 | Bestätigt | MLV & Co | Buy |
| 2012-04-17 | Eingeleitet | Cantor Fitzgerald | Buy |
| 2012-02-29 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2011-11-10 | Bestätigt | MLV & Co | Buy |
| 2011-06-03 | Eingeleitet | Wedbush | Outperform |
| 2011-03-04 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2010-03-09 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2009-08-26 | Hochstufung | Avondale | Mkt Perform → Mkt Outperform |
Alle ansehen
Cerus Corp Aktie (CERS) Neueste Nachrichten
Cerus Corporation Announces Executive Chairman Transition and Employment Agreement Amendment – SEC 8-K Filing July 2026 - Minichart
Cerus Corporation (CERS) defines pay and term for William Greenman as Executive Chairman - Stock Titan
Cerus Corp faces a complex landscape as blood safety technology evolves - ad-hoc-news.de
ETFs Investing in Cerus Corporation Stocks - TradingView
Cerus Corp updates focus on blood safety. Business model supports long-term growth - ad-hoc-news.de
Cerus Corp looks to blood safety technology as investors weigh long-term growth - ad-hoc-news.de
Cerus Company Profile & Introduction - Moomoo
CERSCerus Corp Latest SEC Filings - Finviz
Cerus CFO Kevin Green sells $99,105 in CERS shares - Investing.com
Cerus COO Vivek Jayaraman disposes of $124,658 in stock for taxes - Investing.com
Cerus CEO William Greenman sells $299,937 in common stock - Investing.com
Form 4 Cerus Corporation For: 2 July By Investing.com - Investing.com Canada
Cerus CEO William Greenman sells $299,937 in common stock By Investing.com - Investing.com Canada
Cerus (CERS) CFO logs tax-related share sale and new stock grant - Stock Titan
Cerus (CERS) COO granted RSUs, performance rights and sells shares - Stock Titan
Cerus (NASDAQ: CERS) CLO reports Rule 10b5-1 tax sale and 55,000-share grant - Stock Titan
CERUS (CERS) CEO Greenman logs tax-related share sale and 192,500-share grant - Stock Titan
Cerus Corp (CERS) Institutional Confidence - TradingKey
Cerus StockFriday sector check and transfusion focus - AD HOC NEWS
CERUS CORP (CERS) Stock Chart - ChartMill
Cerus Corp (CERS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Cerus Corp (CERS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Cerus Corp (CERS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Cerus Corp (CERS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Cerus Corp (CERS) Valuation: PE, PB & Fair Value Analysis - TradingKey
Cerus Corp (CERS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Cerus Corp (CERS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Cerus Corp (CERS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Cerus takes INTERCEPT blood system data to global transfusion congress - Stock Titan
Cerus Corporation (CERS) Closes New Debt Facility of Up to $110M - Insider Monkey
5 Best Genomics Stocks to Buy According to Analysts - Insider Monkey
Cerus Corporation (NASDAQ:CERS) Sees Significant Decrease in Short Interest - MarketBeat
Cerus Corp director Eric Bjerkholt sells $53,180 in stock By Investing.com - Investing.com Australia
Director Eric Bjerkholt Sells 20,454 Shares of Cerus Corp (CERS) - GuruFocus
Cerus Corp director Eric Bjerkholt sells $53,180 in stock - Investing.com UK
Cerus Corp (CERS) director sells 20,454 common shares in open-market trade - Stock Titan
[144] CERUS CORP SEC Filing - Stock Titan
CERS Secures $110M Debt Facility for Enhanced Financial Flexibil - GuruFocus
Cerus Refinances Credit Facilities: $65 Million Term Loan and $30 Million Revolver With MidCap - TradingView
Cerus (NASDAQ: CERS) refinances $65M term loan and $30M revolver - Stock Titan
Cerus secures $110 million debt facility with MidCap Financial By Investing.com - Investing.com Canada
Cerus secures $110 million debt facility with MidCap Financial - Investing.com
$110M refinancing expected to save Cerus up to $3.5M a year - Stock Titan
CERS News | CERUS CORP (NASDAQ:CERS) - ChartMill
Should I buy Cerus (CERS) - Zacks Investment Research
Cerus (NASDAQ: CERS) holders back equity plan, board and auditors - Stock Titan
Cerus COO Vivek Jayaraman sells $50,001 in company stock By Investing.com - Investing.com Nigeria
Cerus COO Vivek Jayaraman sells $50,001 in company stock - Investing.com
Cerus (NASDAQ: CERS) director granted 60,000 RSUs under 2024 equity plan - Stock Titan
Cerus (CERS) director receives 60,000 RSUs under 2024 equity plan - Stock Titan
Cerus (CERS) director Jami Nachtsheim awarded 60,000 RSUs, lifting holdings to 268,362 shares - Stock Titan
Finanzdaten der Cerus Corp-Aktie (CERS)
Umsatz
Nettogewinn
Free Cashflow
ENV
Cerus Corp-Aktie (CERS) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Jayaraman Vivek K | Chief Operating Officer |
Jun 30 '26 |
Sale |
2.94 |
42,359 |
124,658 |
1,694,348 |
| Jensen Chrystal | Chief Legal Officer |
Jun 30 '26 |
Sale |
2.94 |
24,329 |
71,598 |
966,657 |
| Greenman William Mariner | President and CEO |
Jun 30 '26 |
Sale |
2.94 |
101,919 |
299,937 |
5,053,036 |
| BJERKHOLT ERIC | Director |
Jun 09 '26 |
Sale |
2.60 |
20,454 |
53,180 |
261,679 |
2.36%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):